Clinical trial

PRevention of Macular EDema After Cataract Surgery

NCT01774474

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-07-10

PhasePHASE3

Study timeline

Study start (actual)2013-07-10Date precision: day

Registry last updated2017-04-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cystoid Macular Edemaunresolved

Cataractunresolved

Diabetes Mellitusunresolved

Interventions

BromfenacDRUG · verified · RxNorm: bromfenac

DexamethasoneDRUG · verified · RxNorm: dexamethasone

BevacizumabDRUG · verified · RxNorm: bevacizumab

Triamcinolone AcetonideDRUG · verified · RxNorm: triamcinolone acetonide

Sponsors & collaborators

Maastricht University Medical Centerlead sponsor

European Society of Cataract and Refractive Surgeonscollaborator

Mapped research locations

ViennaAustria2 AmsterdamNetherlands2 BarcelonaSpain1 BudapestHungary1 MaastrichtNetherlands1 EdegemBelgium1 CoimbraPortugal1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01774474 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.